|
1. FDA refuses to review Moderna flu vaccine Full story
2. War breaks out over GLP-1 pills Full story
3. How will healthcare's new power brokers reshape care delivery in 2026? Get answers here.
4. The medication-driven strategy shifting cancer care at WVU Medicine Full story
5. Amgen declines FDA request to withdraw rare disease drug Full story
6. New data: How value analysis and pharmacy leaders evaluate products now. Results here.
7. FDA rejects Regenxbio's rare disease gene therapy Full story
8. CVS: 4 drug candidates to watch Full story
Becker's Learning Opportunities
9. How will healthcare's new power brokers reshape care delivery in 2026? Get answers here.
10. Healthcare creates 30% of the world’s data — yet 97% goes unused. Fix trust gaps here.
11. New data shows how purchasing committees evaluate drugs, devices + supplies today. Find it here.
12. Interested in more? See Becker’s full lineup of
webinars and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
